Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Holvoet

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Pathology|December 17, 2016
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitisSophie Van Welden, Martine De Vos, Ben Wielockx, et al.
Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]Jeroen Geldof, Marie Truyens, Michiel Hanssens, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Pathology|December 17, 2016
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitisSophie Van Welden, Martine De Vos, Ben Wielockx, et al.
Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]Jeroen Geldof, Marie Truyens, Michiel Hanssens, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Pageof 3